EXCLUSIVE: Anixa Biosciences Tells Benzinga 'IND follows encouraging findings of necrosis, inflammation and T cell infiltration in tumor biopsy of patient in lowest dose cohort'
EXCLUSIVE: Anixa Biosciences Tells Benzinga 'IND follows encouraging findings of necrosis, inflammation and T cell infiltration in tumor biopsy of patient in lowest dose cohort' | Quantisnow
